TD2 Receives Three-Year Renewal of AAALAC Accreditation

July 18, 2018

We’re pleased to announce that our preclinical laboratory has again earned a Full Accreditation from AAALAC International Council.

TD2 has held AAALAC accreditation since 2010, and we’re thrilled that the 2018 renewal continues that succession through 2021.

In their letter of notification, the AAALAC Council on Accreditation made special recognitions of the following features of our preclinical facility, staff and resources:

– Our administrative commitment to the program, along with the caliber of our documentation throughout it.

– The engagement of our Institutional Animal Care and Use Committee.

– The level of sanitation, cleanliness and organization in our facility.

– Our Occupational Health & Safety signage.

– Our tumor monitoring guideline.

– Our heating, ventilation and air conditioning monitoring system.

– Our storage and documentation practices for controlled substances.

We’re proud to support humane and responsible animal treatment throughout all ends of our scientific research, and we’re honored to continue this voluntary accreditation for years to come.

Want to learn more about our AAALAC-accredited preclinical lab? Ask us for a tour!

The Importance of Incorporating Metabolomic and Proteomic Screening in Preclinical Oncology Studies

The evolving complexity of oncology drug development demands an equally sophisticated approach to understanding the tumor microenvironment and its ...

Read more +

Challenges in Radiopharmaceutical Development for Oncology Therapies

Radiopharmaceuticals offer tremendous promise in oncology by providing both diagnostic and therapeutic benefits. However, the field faces several ...

Read more +

Emerging Trends in Radiopharmaceuticals

EVOLVING CLINICAL STRATEGIES Radiopharmaceuticals represent a significant advancement in oncology by integrating targeted radiation with biologically ...

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.